New HAE drug shows promise in early trial
NCT ID NCT05695248
First seen May 10, 2026 · Last updated May 22, 2026 · Updated 4 times
Summary
This study tested a new drug called navenibart (STAR-0215) in 29 adults with hereditary angioedema (HAE), a condition causing painful swelling attacks. Participants received one or two doses to check safety and how well it reduces attacks. The goal is to find a treatment that controls HAE with fewer doses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AARA Research Center
Dallas, Texas, 75231, United States
-
Acuro Research, Inc.
Little Rock, Arkansas, 72205, United States
-
Addenbrooke's Hospital
Cambridge, CB2 0QQ, United Kingdom
-
Allergy & Asthma Clinic of Northwest Arkansas
Bentonville, Arkansas, 72712, United States
-
Allergy & Asthma Clinical Research
Walnut Creek, California, 94598, United States
-
Allervie Clinical Research
Birmingham, Alabama, 35209, United States
-
Charité Universitätsmedizin Berlin
Berlin, 12203, Germany
-
Diagnostical Consultative Center Convex Ltd.
Sofia, 1680, Bulgaria
-
Institute for Asthma and Allergy, PC
Chevy Chase, Maryland, 20815, United States
-
Institute of Clinical Immunology/Allergology, Faculty Hospital
Hradec Králové, 500 05, Czechia
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Medical Research of Arizona a Division of Allergy, Asthma & Immunology Associates, LTD.
Scottsdale, Arizona, 85251, United States
-
Optimed Research
Columbus, Ohio, 43235, United States
-
Ottawa Allergy Research Corporation
Ottawa, Ontario, K1H 1E4, Canada
-
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Raffi Tachdjian MD, Inc
Santa Monica, California, 90404, United States
-
St. James's Hospital
Leeds, LS9 7TF, United Kingdom
-
UC San Diego US HAEA Angioedema Center
San Diego, California, 92122, United States
-
University of Alberta
Edmonton, Alberta, T6G 2R3, Canada
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.